Wells Fargo Maintains Overweight on National Health Investors, Raises Price Target to $69
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst James Feldman maintains an Overweight rating on National Health Investors (NYSE:NHI) and raises the price target from $63 to $69.
May 30, 2024 | 5:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst James Feldman maintains an Overweight rating on National Health Investors (NYSE:NHI) and raises the price target from $63 to $69.
The Overweight rating and increased price target from a reputable analyst at Wells Fargo is likely to positively impact NHI's stock price in the short term as it signals confidence in the company's performance and potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100